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Abstract
The type III interferon (IFNl) receptor IL-28R is abundantly expressed in the respiratory tract and has been shown essential
for host defense against some viral pathogens, however no data are available concerning its role in the innate immune
response to bacterial pathogens. Staphylococcus aureus and Pseudomonas aeruginosa induced significant production of
IFNl in the lung, and clearance of these bacteria from the lung was significantly increased in IL-28R null mice compared to
controls. Improved bacterial clearance correlated with reduced lung pathology and a reduced ratio of pro- vs anti-
inflammatory cytokines in the airway. In human epithelial cells IFNl inhibited miR-21 via STAT3 resulting in upregulation of
PDCD4, a protein known to promote inflammatory signaling. In vivo 18 hours following infection with either pathogen,
miR-21 was significantly reduced and PDCD4 increased in the lungs of wild type compared to IL-28R null mice. Infection of
PDCD4 null mice with USA300 resulted in improved clearance, reduced pathology, and reduced inflammatory cytokine
production. These data suggest that during bacterial pneumonia IFNl promotes inflammation by inhibiting miR-21
regulation of PDCD4.
Citation: Cohen TS, Prince AS (2013) Bacterial Pathogens Activate a Common Inflammatory Pathway through IFNl Regulation of PDCD4. PLoS Pathog 9(10):
e1003682. doi:10.1371/journal.ppat.1003682
Editor: Ambrose Cheung, Geisel School of Medicine at Dartmouth, United States of America
Received April 24, 2013; Accepted August 21, 2013; Published October 3, 2013
Copyright:  2013 Cohen and Prince. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by an NIH grants (R01HL079395, R01HL073989) to ASP and Parker B. Francis Fellowship to TSC. The funders had no role in the
study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: asp7@columbia.edu
Introduction
The interferon (IFN) family is composed of three subgroups
(types I, II, and III IFN), and through their distinct receptors, IFNs
signal through STAT transcription factors to upregulate expres-
sion of over 300 IFN dependent genes. In the lung bacterial
pathogen associated molecular patterns (PAMPs) can be internal-
ized and thus gain access to the intracellular receptors involved in
type I IFN signaling [1–3]. Activation of type I IFN signaling can
be either protective or detrimental to the host depending on the
specific pathogen [4–9]. Type I IFNs promote the pathogenesis of
Staphylococcus aureus pulmonary infection through upregulation of
CXCR3 chemokines and T-cell recruitment while improving
eradication of Pseudomonas aeruginosa by reducing inflammasome
signaling [1,10–16].
Interferons induce expression of downstream genes through
distinct receptors. Type I IFN signals through the ubiquitously
expressed interferon-a/b receptor (IFNAR), while the type III IFN
(IFNl) family, composed of IL-28A/B and IL-29, signals through
the more cell specific receptor complex of IL-10R2 and IL-28R
[17–21]. Following activation of either IFN pathway, an autocrine
signaling network mediates the cellular response, primarily
through JAK/STAT signaling and the induction of IFN depen-
dent gene expression. It would seem that the two IFNs activate
redundant downstream signaling pathways. However altered
signaling kinetics and the limited distribution of IL-28R, restricted
primarily to mucosal tissues, suggest distinct roles for type I and
type III IFN depending on the infection site [22–28]. For example
in the lung type III IFN is the primary IFN produced by
respiratory epithelial cells in response to viral stimulation and is
required for clearance of influenza from the airway [29–32].
Several of the immunological effects of IFNl such as upregulation
of MHC I and II, induction of NF-kB dependent cytokine
production and effects on DC maturation and differentiation,
could be highly relevant to the pathogenesis of bacterial infection
[33–36].
Interferon signaling is linked to the regulation of micro RNAs,
small non-coding RNA inhibitors of mRNA translation capable of
directly influencing innate immune signaling [4–9]. In tumor cells,
miR-21 targets the tumor suppressor programmed cell death
protein 4 (PDCD4) promoting tumor growth and contributing to
the inflammatory tumor microenvironment [1,10–16]. PDCD4
represses translation of cellular mRNA through its binding to
eukaryotic initiation factor 4A (eIF4A) [17–21]. Phosphorylation
of PDCD4 by the ribosomal S6 kinase (p70S6K) results in release
of eIF4A from PDCD4, ubiquitin dependent degredation of
PDCD4, and enhanced mRNA translation [22–28]. Inflammatory
cytokine production in response to toll like receptor (TLR) 2 or 4
activation by decorin or lipopolysaccharide (LPS) is significantly
influenced by expression of miR-21 and PDCD4 [29–32].
Therefore the pro-inflammatory contribution of PDCD4 to host
signaling during bacterial pneumonia could significantly contrib-
ute to lung pathology [33–36].
In the experiments detailed in this report, we examined the
importance of type III IFNs in the innate immune response to two
major airway pathogens, USA300 MRSA and P. aeruginosa,
currently the most common causes of ventilator associated
pneumonia [37,38]. We found that IFNl is induced in the course
of bacterial airway infection and results in downregulation of the
microRNA miR-21, sustained expression of PDCD4, and
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increased proinflammatory cytokine production. Mice lacking the
IFNl receptor, IL-28R, or PDCD4 had significantly improved
clearance of both airway pathogens and less pulmonary pathology
associated with reduced levels of inflammatory cytokines.
Results
IL-28R2/2 mice are more resistant to S. aureus respiratory
infection
In vitro studies were performed to establish the kinetics of IFNl
induction in response to the extracellular bacterial pathogen S.
aureus. A significant increase in IFNl transcript (p , 0.001) was
observed in wild type (WT) bone marrow derived dendritic cells
(BMDCs) following 4 hours of stimulation with heat killed
USA300, which returned to baseline by 8 hours (Fig. 1A). Similar
induction was observed when BMDCs were stimulated with live
bacteria (MOI 100, 4 hours), and induction was significantly
reduced (p= 0.0062) in IL-28R2/2 BMDCs (Fig. S1A).
To evaluate the role of type III IFN in MRSA pneumonia we
infected WT C57BL/6 and IL-28R2/2 mice intranasally with
16107 CFU USA300. IFNl mRNA levels increased significantly
by 4 hours in the lung of WT mice (p= 0.0047) (Fig. S1B), and
protein levels were significantly increased in the airway of WT
mice by 4 (p = 0.0051) and 18 (p , 0.0001) hours post infection
(Fig. 1B). By 4 hours following intranasal infection the numbers of
bacteria recovered from the airway were significantly reduced in
IL-28R2/2 mice compared with control (p = 0.0178) (Fig. 1C), a
difference not observed in the lung tissue (Fig. 1D). By 18 hours
significantly fewer bacteria were recovered from both the airway
(p = 0.0002) and tissue (p = 0.0043) of knockout mice compared to
control. Lung pathology was reduced in IL-28R2/2 compared to
WT controls as determined by trichrome stained lung sections
(Fig. 1E). The numbers of dendritic cells, macrophages, or
neutrophils recruited to the airway (Fig. 1F) or lung tissue
(Fig. 1G) were not affected by lack of IL-28R, suggesting that
differences in bacterial clearance and pathology were not due to
increased numbers of phagocytotic cells.
Expression of inflammatory cytokines is enhanced by
type III IFN
Type III IFN activates a family of over 300 genes through a Jak-
Stat signaling cascade [39,40]. We analyzed expression of
cytokines in the bronchial alveolar lavage (BAL) of wild type
and IL-28R2/2 mice following 4 and 18 hour MRSA infection by
ELISA. Significant differences in cytokine expression were not
observed following a short (4 hour) infection suggesting that initial
activation of cytokine production does not depend on signaling
through IL-28R. By 18 hours significant reductions in KC (p ,
0.0001), GM-CSF (p = 0.0009) and IL-1b (p = 0.0002) but not
TNF or IL-10 were observed in IL-28R2/2 as compared with WT
mice (Fig. 2A). Levels of the interferon response gene MX1 were
reduced in IL-28R2/2 mice compared to WT at the 18 hour
time point, confirming the inhibition of interferon signaling
(Fig. 2B). Installation of recombinant IFNl did not significantly
increase cytokine expression in the BAL of uninfected mice
(Fig. S2). Therefore it appears that IFNl does not directly
induce cytokine production, but is more likely involved in the
regulation of inflammatory cytokines during acute S. aureus
infection.
The pro-inflammatory cytokine IL-1b has shown to promote
lung injury during P. aeruginosa pneumonia, and was significantly
decreased in the airways of S. aureus infected IL-28R2/2 mice
[11]. To determine if decreased IL-1b was similarly associated
with the improved outcome of the IL-28R2/2 mice, we
predicted that Anakinra, a synthetic IL-1R antagonist, would
improve clearance of S. aureus from the lung and reduce lung
pathology. Numbers of bacteria recovered 18 hours following
infection with USA300 were significantly lower from the airway
(p = 0.0336) (Fig. 2C) and lung (p = 0.0088) (Fig. 2D) of
Anakinra treated compared to PBS pretreated controls. Lung
pathology was reduced in Anakinra treated mice following an 18
hour infection compared to infected control mice (Fig. 2E).
These data suggest that the reduced pathology observed in IL-
28R null mice was due in part to reduction in the inflammatory
cytokine IL-1b.
Type III IFN regulates PDCD4 expression in epithelial cells
PDCD4 has been shown to promote inflammatory cytokine
production in response to LPS, and reduction of PDCD4
expression in human epithelial cell monolayers (16HBE)
significantly reduced IL-8 induction (p= 0.0103) in response to
USA300 (Fig. 3A) [31]. Since PDCD4 expression is regulated by
the micro RNA miR-21, we tested whether IFNl promotes
inflammatory signaling by inhibiting miR-21 expression. In vitro,
miR-21 expression in 16HBEs was reduced following 1 hour
treatment with recombinant IFNl (Fig. 3B), which correlated
with an increase in PDCD4 protein levels (Fig. 3C). Re-
duction of miR-21 (Fig. 3D) and increased PDCD4 expression
(Fig. 3E) following IFNl treatment was dependent on STAT3
phosphorylation.
S. aureus SpA induced PDCD4 expression
In response to acute LPS exposure macrophages upregulate
PDCD4 expression [31]. S. aureus, as a Gram positive pathogen,
can induce inflammatory signaling in epithelial cells through
interaction of its major surface component protein A (SpA) and
host receptor TNFR1 [13,41–43]. We hypothesized that SpA-
TNFR1 interaction would upregulate PDCD4 expression and
promote production of inflammatory cytokines. 16HBE epithelial
cells were exposed to S. aureus protein A (SpA) and increases in the
expression of PDCD4 (p= 0.0068) were observed (Fig. 3F). To
confirm the relationship between TNFR1 and PDCD4, we pre-
treated 16HBEs with antibody to the extracellular domain of
TNFR1 and demonstrated significantly reduced induction of
PDCD4 by SpA compared to IgG pretreatment (p = 0.029)
(Fig. 3G). These data demonstrate that SpA, like LPS, is able to
induce expression of PDCD4 in host cells.
Author Summary
The role of interferons (types I, II, and III) in viral and
bacterial infections has been a topic of intense research
over the last decade. The contribution of the type I
interferons during bacterial pneumonias particularly has
been shown to be highly variable depending on the
specific pathogen. Our data for the first time demonstrate
that type III interferon plays a significant role in the
pathogenesis of bacterial pneumonia, and its contribution
is similar in both Gram positive and Gram negative
infections. We show in epithelial cells that miR-21 and
PDCD4 are downstream effectors of type III interferon that
prolong production of inflammatory cytokines. Utilizing
mice that lack the receptor for type III interferon or PDCD4,
we show that inhibiting this pathway improves bacterial
clearance from the airways and lung tissue. These data
suggest novel targets for therapy in a variety of bacterial
pneumonias.
Bacterial Pathogens Activate IFNl
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PDCD4 expression inversely correlates with clearance of
USA300
In vivo, miR-21 expression in WT and IL-28R null mice was
not different prior to infection. Expression of miR-21 increased by
greater than 10-fold in both WT and IL-28R null mice following
four hour infection with USA300 (Fig. 4A). By 18 hours following
the initial infection miR-21 levels in WT mice returned to
uninfected levels, while levels in IL-28R null mice remained
significantly higher (p = 0.002). PDCD4 mRNA levels following 18
hour infection inversely correlated with miR-21 expression, and
were significantly lower in IL-28R null mice compared to WT
(p= 0.045) (Fig. 4B). PDCD4 protein expression at the 4 hour
time point was reduced in both WT and IL-28R2/2 mice
compared to unstimulated levels, and reduced further at the 18
hour time point (Fig. 4C). PDCD4 protein expression tended to
be lower at the 18 hour time point in IL-28R null mice than WT,
correlating with elevated levels of miR-21. Thus it appears that
following the initial pro-inflammatory innate immune response to
S. aureus in WT mice, IFNl signaling suppresses expression of
miR-21 maintaining PDCD4 levels. Loss of IL-28R resulted in
sustained miR-21 levels and a decrease in PDCD4 gene expression
by 18 hours of S. aureus infection.
To confirm that PDCD4 expression negatively influences
clearance of USA300 from the airway we infected WT and
PDCD42/2 mice with 107 CFU USA300 for 18 hours. Signifi-
cantly fewer organisms were recovered from both the airway
(p = 0.007) (Fig. 4D) and lung tissue (p = 0.014) (Fig. 4E) of
PDCD42/2 mice compared to WT. Bacterial clearance correlated
with reduced lung pathology (Fig. 4F) but not immune cell
recruitment into the lung (Fig. S3). Expression of the inflamma-
tory cytokines KC and IL-1b, not TNF, were reduced and ex-
pression of anti-inflammatory IL-10 was increased in PDCD42/2
mice compared to WT. Although differences in cytokines were not
statistically significant, the trends were similar to those observed in
IL-28R2/2 compared to WT suggesting a link between type III
IFN and PDCD4.
Type III IFN promotes Gram negative pneumonia
Due to previous reports demonstrating improved survival of
PDCD42/2 mice during LPS challenge, we hypothesized that
IL-28R2/2 mice would clear the Gram negative pathogen
P. aeruginosa PAK more rapidly than WT mice [31]. In vitro,
P. aeruginosa PAK stimulation (MOI 10, 4 hours) of BMDCs
induced increased mRNA levels of IFNl compared to
Figure 1. Induction of IFNl by S. aureus USA300 inhibits bacterial clearance. (A) qRT-PCR analysis of IFNl mRNA in BMDCs stimulated with
heat killed USA300, m 6 SD. (B) ELISA analysis of IFNl in BAL of WT mice following 4 and 18 hours of infection with USA300. (C) Numbers (CFU) of
USA300 recovered from BAL of WT and IL-28R2/2 mice following 4 and 18 hours of infection. (D) Numbers (CFU) of USA300 recovered from lung
tissue of WT and IL-28R2/2 mice following 4 and 18 hours of infection. (E) Trichrome stained lungs from WT and IL-28R2/2 mice following and 18
hour USA300 infection (original magnification 100x, insert 400x). (F) Numbers of dendritic cells (DC), macrophages (MAC), and neutrophils in BAL of
WT and IL-28R2/2 in unstimulated (NS) mice or following 4 or 18 hours of infection. (G) Numbers of dendritic cells (DC), macrophages (MAC), and
neutrophils in lung tissue of WT and IL-28R2/2 in unstimulated (NS) mice or following 4 or 18 hours of infection. Data are representative of at least 2
independent experiments.
doi:10.1371/journal.ppat.1003682.g001
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unstimulated cells (Fig. S1C). As shown for MRSA in Figure S1A,
loss of IL-28R resulted in reduced IFNl mRNA levels following P.
aeruginosa stimulation.
WT and IL-28R null mice were intranasally infected with 107
CFU PAK and bacterial clearance from the airway and lung tissue
monitored at 4 and 18 hours of infection. In vivo, IFNl mRNA
levels (p = 0.0031) (Fig. S1D) and protein expression (p= 0.005)
(Fig. 5A) were significantly increased in WT mice by 4 hours post
infection, but were not different than baseline at the 18 hour time
point. Significantly fewer bacteria were recovered from BAL
(p= 0.0003) (Fig. 5B) and lung tissue (p = 0.0023) (Fig. 5C) of IL-
28R2/2 at the 18 hour time point compared to WT, and no
differences were observed at the 4 hour time point. Bacterial
clearance was not altered in mice lacking the type I IFN receptor
IFNAR (Fig. 5D). Pathology in the lung was reduced in knockout
mice following PAK infection (p = 0.0010) (Fig. 5E). Similar to S.
aureus infection, there were no differences in the numbers of
immune cells recruited to the BAL or lung (Figs. 5F and 5G).
BAL fluid was analyzed for the presence of pro- and anti-
inflammatory cytokines to determine if IFNl signaling increased
expression of pro-inflammatory cytokines during PAK infection.
Significant reductions in expression of pro-inflammatory cytokines
KC (p= 0.0141) and TNF (p= 0.0006) were observed in BAL of
IL-28R null mice at 18 hours compared to WT (Fig. 6A). The
anti-inflammatory IL-10 was significantly increased (p = 0.0134) in
the IL-28R2/2 mice as compared to controls at this time point.
No differences in IL-1b production were observed. MX1 levels
were lower in IL-28R null mice at 18 hours compared to WT
(Fig. 6B).
We then determined if the reduced pro-inflammatory cytokine
expression in IL-28R2/2 mice infected with PAK was also due to
alterations in miR-21 and PDCD4. In vitro, PDCD4 siRNA
significantly reduced IL-8 expression (p= 0.0069) in 16HBE in
response to PAK (Fig. 6C). MiR-21 expression in lung tissue of
IL-28R null mice was increased (p = 0.0122) compared to WT at
18 hours, demonstrating that loss of IFNl signaling resulted in
increased expression of this miRNA during PAK infection (Fig.
6D). PDCD4 mRNA levels were significantly decreased in IL-28R
null mice compared to WT correlating with the changes in miR-
21 level (p = 0.0323) (Fig. 6E). PDCD4 protein in the lung was
almost undetectable at the 4 hour time point. PDCD4 levels
increased slightly by 18 hours although no differences were
observed between knockout and WT mice (Fig. 6F).
PDCD4 function can be regulated by p70S6K dependent
phosphorylation at serine 475, which inhibits its interaction with
AP-1 and eukaryotic translation initiation factor 4A (eIF4A)
Figure 2. Cytokine production during USA300 infection contributes to pathology. (A) ELISA analysis of individual cytokines in BAL of WT
and IL-28R2/2 mice. (B) Western blot analysis of MX1 expression in lungs of WT and IL-28R2/2 mice following 4 and 18 hours of infection with
USA300. (C) Numbers (CFU) of USA300 recovered from the BAL of from PBS control and Anakinra pre-treated mice following an 18 hour infection. (D)
Numbers of USA300 (CFU) recovered from the lung of from PBS control and Anakinra pre-treated mice following an 18 hour infection. (E) Trichrome
stained lungs from PBS control and Anakinra pre-treated mice following and 18 hour USA300 infection (original magnification 100x, insert 400x). Data
are representative of at least 2 independent experiments.
doi:10.1371/journal.ppat.1003682.g002
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transcription factors and leads to ubiquitin dependent degradation
[22,33,44-46]. In vitro stimulation of 16HBE monolayers with
recombinant IFNl for 1 hour reduced phosphorylation of
p70S6K, suggesting that type III IFN inhibits this regulatory
pathway (Fig. 6G). In vivo we observed phosphorylation of
PDCD4 in uninfected IL-28R2/2 mice compared to WT control.
In both WT and knockout mice phosphorylation of p70S6K
increased following 18 hour PAK infection (Fig. 6H), not
observed during MRSA infection (Fig. 6I). Phosphorylation of
PDCD4 in PAK infected WT mice also increased following
18 hours, correlating with phosphorylation of p70S6K. These data
suggest that modifications to PDCD4, mediated by both miR-21
and p70S6K, regulate its ability to influence cytokine production
during P. aeruginosa pneumonia.
Discussion
Much like the other members of the IFN family, IFNl is
required for host defense against viral pathogens and is capable of
inhibiting tumor growth [23–28,30,47,48]. There is clearly a
major role for IFNl in the successful clearance of the hepatitis C
virus consistent with expression of IL-28R on hepatocytes [49,50].
Type III IFN has also been linked to killing of the intracellular
bacterial pathogen Listeria monocytogenes, correlating with reduced
colonization of the spleen and liver [51]. Fitting with the
abundance of IL-28R in the respiratory tract, we found a major
role for IFNl signaling in the pathogenesis of both S. aureus and
P. aeruginosa pneumonia [21,28].
In contrast to the beneficial effects of IFNl in the eradication of
viral pathogens, our data suggest that IFNl promotes a prolonged
inflammatory cytokine response to bacterial pathogens that
detracts from the efficiency of bacterial clearance and promotes
pathology. Mice lacking the type III IFN receptor demonstrated
significantly improved clearance of S. aureus and P. aeruginosa
coincident with a reduced duration of the host inflammatory
response. Particularly in the pathogenesis of pneumonia, the
balance between pro and anti-inflammatory signaling is critical.
While the mechanism through which the inflammatory milieu
affects bacterial clearance is unclear, our data clearly demonstrate
that reducing levels of inflammatory cytokines through modulation
of IFNl or inhibition of IL-1R improves clearance of S. aureus and
P. aeruginosa [11]. Once a sufficient number of phagocytes are
recruited to the airways to deal with the pathogens, excessive
cytokine production, particularly toxic cytokines such as IL-1b,
elicits tissue damage and impairs normal host defenses.
A major effector of IFNl signaling is PDCD4, which appears to
be regulated by multiple pathways in response to infection. A
confirmed target of miR-21, PDCD4 influences production of pro-
inflammatory signaling through its interaction with AP-1, NF-kB,
and eIF4A, and has been linked to the inflammatory microenvi-
ronment surrounding tumor cells [10,12,29,31,33,52]. Similar to
previous findings with LPS, S. aureus SpA, through its interaction
with TNFR1 upregulates PDCD4 in epithelial cells, promoting
pro-inflammatory signaling while inhibiting anti-inflammatory
cytokine production. It is likely that additional S. aureus pathogen
associated molecular patterns (PAMPs) such as the lipoproteins
that activate TLR2 also participate.
Following ligation of IL-28R by IFNl, STAT3 suppresses
expression of miR-21 resulting in increased expression of PDCD4.
MiRNAs like miR-21 comprise a regulatory system which makes
subtle changes to mRNA expression levels, including the genes
involved in Toll-like receptor signaling, and therefore are capable
of having significant affects on innate immunity [7–9,31,53]. MiR-
21, specifically, is induced by NF-kB signaling and has been
Figure 3. IFNl regulation of miR-21 and PDCD4. (A) qRT-PCR analysis of IL-8 in 16HBE cells treated with control or PDCD4 siRNA and infected
with USA300, m 6 SD. (B) qRT-PCR analysis of miR-21 in 16HBE cells treated with recombinant IFNl for 1 hour, m 6 SD. (C) Western blot analysis of
PDCD4 in 16HBE cells treated with recombinant IFNl. (D) qRT-PCR analysis of miR-21 in 16HBE cells pretreated with STAT3 inhibitor or DMSO treated
with recombinant IFNl for 1 hour, m 6 SD. (E) Western blot analysis of PDCD4 in 16HBE cells pretreated with STAT3 inhibitor or DMSO treated with
recombinant IFNl for 1 hour. Lysate from 16HBE cells treated with DMSO and IFNl was used as a positive control (pos). (F) Western blot analysis of
PDCD4 in human epithelial cells (16HBE) following stimulation with S. aureus protein A (SpA), m 6 SD. (G) Western blot analysis of PDCD4 in 16HBE
cells treated with anti-TNFR1 or control IgG and SPA for 2 hours, m 6 SD. Data are representative of at least 2 independent experiments.
doi:10.1371/journal.ppat.1003682.g003
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implicated in the regulation of TLR2 mediated signaling in both
skin and lung inflammation [33,54–57]. We similarly observe
rapid increases in miR-21 during the initial 4 hour infection with
either S. aureus or P. aeruginosa, and sustained expression of miR-21
in IL-28R2/2 mice was associated with reduced levels of
inflammatory cytokines in the airway. As predicted by our in
vitro studies, in mice expressing IL-28R reduced levels of miR-21
at 18 hours post infection correlated with prolonged PDCD4
mRNA expression. Mice lacking PDCD4 were better able to clear
USA300 from their lungs, similar to previous findings demon-
strating PDCD4 null mice are resistant to lethal LPS challenge
[31]. Therefore mice lacking IL-28R are less susceptible to S. aureus
and P. aeruginosa induced lung damage due in part to reduced
PDCD4 and a shortened inflammatory response.
A second pathway acting through mTOR and p70S6K
regulates PDCD4 function by phosphorylating PDCD4, inhibiting
its interaction with AP-1 and eIF4A and promoting its degradation
[17,19,22,29]. Our data suggest that type III IFN has an inhibitory
affect on p70S6K and PDCD4 phosphorylation. In vitro IFNl
treatment of epithelial cells reduced p70S6K phosphorylation.
In vivo, PDCD4 was strongly phosphorylated in uninfected
IL-28R2/2 mice while phosphorylation was not observed in
uninfected control mice. Rapid turnover of PDCD4 due to
phosphorylation dependent degradation, or an inability of
PDCD4 to bind eIF4A in IL-18R null mice could further limit
its affects on signaling.
Increases in p70S6K phosphorylation during bacterial infection
were IL-28R independent and were only observed 18 hours
following infection with P. aeruginosa. The ability to activate
different regulatory pathways such as p70S6K signaling could
contribute to the differences in cytokine induction observed during
S. aureus and P. aeruginosa infections. For example levels of TNF and
IL-10 were significantly different between WT and IL-28R2/2
mice during PAK not USA300 infections, whereas IL-1b was
significantly different during a S. aureus infection. Thus IFNl and
PDCD4 are conserved elements in the response to airway
pathogens which clearly have other differential effects in inducing
innate immunity.
The selective expression of IL-28R, substantially more abun-
dant on murine and human epithelial cells than on immune cells
as previously shown and demonstrated by the inability of
macrophages to respond to IFNl (Fig. S4), may also be important
in the specific cytokine responses evoked by the different
pathogens [28]. Epithelial cells are not the primary producers of
Figure 4. IFNl regulates PDCD4 in vivo. (A) qRT-PCR analysis of miR-21 in the lungs of WT and IL-28R2/2 mice following infection
with USA300, m ± SD. (B) qRT-PCR analysis of PDCD4 mRNA in the lungs of WT and IL-28R2/2 mice following infection with USA300, m 6 SD. (C)
Western blot analysis of PDCD4 in the lungs of WT and IL-28R2/2 mice following infection with USA300, m 6 SD. (D) Numbers (CFU) of USA300
recovered from BAL of WT and PDCD42/2 mice following 18 hours of infection. (E) Numbers (CFU) of USA300 recovered from lung tissue of WT and
PDCD42/2 mice following 18 hours of infection. (F) Trichrome stained lungs from WT and PDCD42/2 mice following and 18 hour USA300 infection
(original magnification 100x, insert 400x). (G) ELISA analysis of individual cytokines in BAL of WT and PDCD42/2 mice. Data are representative of at
least 2 independent experiments.
doi:10.1371/journal.ppat.1003682.g004
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IL-1b in response to PAK, therefore IL-1b levels in the airways of
P. aeruginosa infected WT and IL-28R2/2 mice were not different
[11,58]. It is unclear which cells in the lung produce IL-1b in
response to S. aureus. Our data suggest that IL-1b producing cells
express IL-28R, as cytokine levels were significant reduced in IL-
28R null mice. While we do not propose that IL-1b is the sole
cytokine responsible for lung damage in response to S. aureus,
inhibition of this signaling pathway in WT mice does improve
clearance of S. aureus and limits the extent of tissue damage. We
conclude that while the specific cytokines modulated by type III
IFN are different in the context of specific bacterial infections, the
overall affect of inhibiting IL-28R dependent signaling is a
reduction of lung inflammation and improved bacterial clearance.
The type III IFN pathway is recognized as an important host
defense pathway for the eradication of viral infection and tumor
growth and the distribution of the receptor at mucosal sites makes
it an active participant in the innate immune response to bacterial
pathogens as well. While differences in the expression of PAMPs
and their receptors, mechanisms of p70S6K and PDCD4
phosphorylation, and ultimately levels of cytokine expression are
evident in the models of S. aureus and P. aeruginosa pneumonia,
IFNl functions as a central regulator of airway inflammation in
both types of bacterial pneumonia. Given the pathology associated
with excess cytokine induction in the airways, targeting specific
components of the type III IFN/PDCD4 regulatory pathway
could be a potential therapy for limiting lung damage in the setting
of acute airway infection.
Materials and Methods
Ethics statement
Animal work in this study was carried out in strict accord-
ance with the recommendations in the Guide for the Care and
Use of Laboratory Animals of the National Institutes of Health,
the Animal Welfare Act and US federal law. The protocol
was approved by the Institutional Animal Care and Use Com-
mittee (IACUC) of Columbia University (protocol number
AAAC3059).
Bacterial strains
S. aureus strain LAC USA300 and P. aeruginosa strain PAK were
grown on Luria-Bertani agar at 37uC. For infection, LB broth was
inoculated with single colonies and grown overnight at 37uC,
diluted 1:100 in the morning and grown to OD 1.000 (S. aureus) or
0.500 (PAK). S. aureus cultures grown to OD 1.000 were incubated
at 55uC to inactivate the bacteria for heat killed experiments.
Figure 5. P. aeruginosa induction of IFNl signaling inhibits bacterial clearance. (A) ELISA analysis of IFNl in BAL of WT mice following 4 and
18 hours of infection with PAK. (B) Numbers (CFU) of PAK recovered from BAL of WT and IL-28R2/2 mice following 4 and 18 hours of infection. (C)
Numbers (CFU) of PAK recovered from lung tissue of WT and IL-28R2/2 mice following 4 and 18 hours of infection. (D) Numbers of PAK recovered
from lung tissue of WT and IFNAR2/2mice following 18 hours of infection. (E) Trichrome stained lungs from WT and IL-28R2/2mice following and 18
hour PAK infection (original magnification 100x, insert 400x). (F) Numbers of dendritic cells (DC), macrophages (MAC), and neutrophils in BAL of
unstimulated (NS) WT and IL-28R2/2 mice or following 4 or 18 hours of infection. (G) Numbers of dendritic cells (DC), macrophages (MAC), and
neutrophils in lung tissue of unstimulated (NS) WT and IL-28R2/2 mice or following 4 or 18 hours of infection. Data are representative of at least 2
independent experiments.
doi:10.1371/journal.ppat.1003682.g005
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Models of infection
Seven week old C57BL/6 WT, -IL-28R2/2, IFNAR2/2, and
PDCD42/2 mice were intranasally inoculated with 50 ml S. aureus
or P. aeruginosa (1*107 CFU/mouse) as previously described [2,14].
WT and IFNAR2/2 mice were previously described, IL-28R2/2
mice were provided by Bristol Myers Squibb, and PDCD42/2
mice were from Jackson Laboratories [13]. Control mice received
50 ml of PBS. To determine the affect of IFNl on cytokine
production, mice were intranasally treated with 1 mg recombinant
mIL-28 (PBL Interferon Source) in 50 ml PBS or PBS control. The
role of IL-1b was determined in mice pretreated i.p. with Anakinra
(10 mg/kg, Amgen) for four days and were infected on the fourth
day as described previously [59]. Control mice were treated with
PBS also given i.p. BAL fluid was harvested 18 hours after
infection and used to quantify immune cell populations, cytokine
expression, and bacteria CFU. Histology was performed by
Columbia University Molecular Pathology core on tissues fixed
in 4% paraformaldehyde.
Cell culture
Bone marrow- derived dendritic cells (BMDCs) were cultured
from wild-type and knockout mice as described previously [3].
Human airway epithelial cells (16HBE) were grown as previously
described [60]. Human monocytic THP-1 cells were grown in
RPMI 1640 medium with 10% fetal bovine serum with penicillin
(100 units/ml) and streptomycin (100 mg/ml) and treated with
100 nM phorbol 12-myristate 13-acetate (PMA) to induce
terminal differentiation for IFN stimulation studies. On-target
control or PDCD4 siRNA (Thermo Scientific) was transfected into
16HBE monolayers using Fugene (Promega) according to the
manufacturers instructions. Cells were stimulated with 5 mM S.
aureus protein A (Calbiochem) or 0.1 mg/ml human recombinant
IL-28 or IFNb (PBL Interferon). In select experiments antibody to
the extracellular domain of TNFR1 or control IgG (4 mg/ml)
(Santa Cruz Biotechnology Inc.) or STAT3 inhibitor V (50 mM)
(Calbiochem) or DMSO control were applied to 16HBEs 1 hour
prior to SpA.
Figure 6. P. aeruginosa induced cytokine, miR-21, and PDCD4 expression in WT and IL-28R2/2 mice. (A) ELISA analysis of individual
cytokines in BAL of WT and IL-28R2/2 mice. (B) Western blot analysis of MX1 expression in lungs of WT and IL-28R2/2 mice following 4 and 18 hours
of infection with PAK. (C) qRT-PCR analysis of IL-8 in 16HBE cells treated with control or PDCD4 siRNA and infected with PAK, m 6 SD. (D) qRT-PCR
analysis of miR-21 in the lungs of WT and IL-28R2/2 mice following infection with PAK, m 6 SD. (E) qRT-PCR analysis of PDCD4 mRNA in the lungs of
WT and IL-28R2/2 mice following infection with PAK, m 6 SD. (F) Western blot analysis of PDCD4 in the lungs of WT and IL-28R2/2 mice following
infection with PAK, m 6 SD. (G) Western blot analysis of phosphorylation of p70S6K in 16HBE cells treated with recombinant IFNl. (H) Western blot
analysis of phosphorylation of p70S6K and PDCD4 in the lungs of WT and IL-28R2/2 mice following infection with PAK. (I) Western blot analysis of
phosphorylation of p70S6K and PDCD4 in the lungs of WT and IL-28R2/2 mice following infection with USA300. Data are representative of at least 2
independent experiments.
doi:10.1371/journal.ppat.1003682.g006
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FACS analysis
Enumeration of neutrophil (MHCII2Ly6+), macrophages
(CD11c+MHCIIlow), and DC (CD11c+MHCII+) populations was
performed as previously described [1].
ELISA and immunoblotting
BAL was analyzed for cytokine and chemokine content by
ELISA (R&Dbiosystems, PBL Interferon Source, or eBioscience)
according to the manufacture’s instructions. Anti-phospho-
p70S6K, anti-phospho-PDCD4, anti-PDCD4 (Rockland Immu-
nochemicals), anti-MX1 (Santa Cruz Biotechnology Inc.) and anti-
b-actin (Sigma) antibodies followed by secondary antibodies
conjugated to horseradish peroxidase (Santa Cruz Biotechnology
Inc.) were used to measure expression in human epithelial cells
and mouse lung. Protein separation, transfer and immunnoblot-
ting were performed as described [13]. Densitometry was done
using Image J (NIH).
mRNA and miRNA analysis
Total RNA was isolated using mirVana miRNA Isolation Kit
(Life Technologies) according to the manufacturers instructions. For
mRNA analysis cDNA was generated using the High Capacity
cDNA reverse Transcriptase Kit (Applied Biosystems). Quantitative
real-time RT-PCR (QRT-PCR) was performed using Power SYBR
Green PCR Master Mix in a Step One Plus Thermal Cycler
(Applied Biosystems). Mouse primers for PDCD4 were 59 –
ATGGATATAGAAAATGAGCAGAC -39 and 59 – CCAGAT
CTGGACCGCCTATC -39 and actin were 59 – CCTTTGAA
AAGAAATTTGTCC – 39 and 59 – AGAAACCAGAACTGAA
ACTGG – 39. Human primers for IL-8 were 59-TACTCCAA
ACCTTTCCAACCC-39 and 59- AACTTCTCCACAACCCTC
TG-39 and actin were 59- GTGGGCCGCTCTAGGCACCA-39
and 59-CGGTTGGCCTTAGGGTTCAGGGGGG- 39. IL-8 and
PDCD4 expression was normalized to actin. For miRNA analysis
cDNA was generated and qRT-PCR was run using NCode miRNA
First-Strand cDNA Synthesis and qRT-PCR Kit (Life Technolo-
gies) according to the manufacturers instructions. A universal
reverse primer for small RNAs was supplied with the NCode kit.
The forward primer for miR-21 was 59-TAGCTTATCAGACT-
GATGTTGA-39 and DCt values were normalized to the small
non-coding RNA U6 59-GGGCAGGAAGAGGGCCTAT-39.
Statistics
Significance of data was determined using a nonparametric
Mann-Whitney test. For experiments with greater than one
comparison we used a nonparametric Kruskal-Wallis test followed
by post-hoc Dunn’s test to correct for multiple comparisons.
Statistics were performed with GraphPad Prism software with
significance defined as p,0.05. Cytokine, bacterial counts, and
immune cell number data are presented as individual points with a
bar representing the median value.
Supporting Information
Figure S1 Induction of IFNl in bone marrow derived
dendritic cells (BMDCs) or Lung tissue. (A) mRNA analysis of
IFNl stimulation following 4 hours of USA300 infection in WT
or IL-28R2/2 BMDCs, normalized to unstimulated cells (NS) m
6 sd. (B) mRNA analysis of IFNl stimulation in the lungs of
WT mice following 4 or 18 hours of USA300 infection. (C)
mRNA analysis of IFNl stimulation following 4 hours of PAK
infection in WT or IL-28R2/2 BMDCs, normalized to
unstimulated cells (NS), m 6 sd. (D) mRNA analysis of IFNl
stimulation in the lungs of WT mice following 4 or 18 hours of
PAK infection. Data are representative of at least 2 independent
experiments.
(TIF)
Figure S2 Induction of cytokines by rIL-28. ELISA analysis of
cytokines in BAL of wt mice 18 hours following intranasal
instillation of rIL-28 (1 mg/mouse). Data are representative of at
least 2 independent experiments.
(TIF)
Figure S3 Immune cell populations in WT and PDCD42/2
mice. FACs analysis of dendritic cell, macrophage, and neutrophil
populations in the BAL and lung tissue of WT and PDCD42/2
mice following an 18 hour infection with USA300. Data are
representative of 2 independent experiments.
(TIF)
Figure S4 Response of human macrophages to type I and III
IFN. Western blot analysis of STAT3 phosphorylation in THP-1
cells stimulated with type I (IFNb) or type III (IFNl) for 30




Conceived and designed the experiments: TSC ASP. Performed the
experiments: TSC. Analyzed the data: TSC. Contributed reagents/
materials/analysis tools: ASP. Wrote the paper: TSC ASP.
References
1. Parker D, Cohen TS, Alhede M, Harfenist BS, Martin FJ, et al. (2012) Induction
of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic
fibrosis epithelial cells. Am J Respir Cell Mol Biol 46: 6–13. doi:10.1165/
rcmb.2011-0080OC.
2. Parker D, Prince A (2012) Staphylococcus aureus induces type I IFN signaling in
dendritic cells via TLR9. J Immunol 189: 4040–4046. doi:10.4049/jimmu-
nol.1201055.
3. Parker D, Martin FJ, Soong G, Harfenist BS, Aguilar JL, et al. (2011) Streptococcus
pneumoniae DNA initiates type I interferon signaling in the respiratory tract. mBio
2: e00016–11. doi:10.1128/mBio.00016-11.
4. David M (2010) Interferons and microRNAs. Journal of Interferon & Cytokine
Research 30: 825–828. doi:10.1089/jir.2010.0080.
5. Trinchieri G (2010) Type I interferon: friend or foe? Journal of Experimental
Medicine 207: 2053–2063. doi:10.1084/jem.20101664.
6. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene
regulation. Nat Rev Genet 5: 522–531. doi:10.1038/nrg1379.
7. Ma X, Becker Buscaglia LE, Barker JR, Li Y (2011) MicroRNAs in NF-kappaB
signaling. J Mol Cell Biol 3: 159–166. doi:10.1093/jmcb/mjr007.
8. O’Neill LA, Sheedy FJ, McCoy CE (2011) MicroRNAs: the fine-tuners of Toll-
like receptor signalling. Nat Rev Immunol 11: 163–175. doi:10.1038/nri2957.
9. Quinn SR, O’Neill LA (2011) A trio of microRNAs that control Toll-like
receptor signalling. International Immunology 23: 421–425. doi:10.1093/
intimm/dxr034.
10. Yasuda M, Schmid T, Ru¨bsamen D, Colburn NH, Irie K, et al. (2010)
Downregulation of programmed cell death 4 by inflammatory conditions
contributes to the generation of the tumor promoting microenvironment. Mol
Carcinog 49: 837–848. doi:10.1002/mc.20660.
11. Cohen TS, Prince AS (2013) Activation of inflammasome signaling mediates
pathology of acute P. aeruginosa pneumonia. J Clin Invest 123: 1630–1637.
doi:10.1172/JCI66142DS1.
12. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, et al. (2008)
Programmed cell death 4 (PDCD4) is an important functional target of the
microRNA miR-21 in breast cancer cells. J Biol Chem 283: 1026–1033.
doi:10.1074/jbc.M707224200.
13. Martin FJ, Go´mez MI, Wetzel DM, Memmi G, O’Seaghdha M, et al. (2009)
Staphylococcus aureus activates type I IFN signaling in mice and humans through
the Xr repeated sequences of protein A. J Clin Invest 119: 1931–1939.
14. Martin FJ, Parker D, Harfenist BS, Soong G, Prince A (2011) Participation of
CD11c(+) leukocytes in methicillin-resistant Staphylococcus aureus clearance from
the lung. Infect Immun 79: 1898–1904. doi:10.1128/IAI.01299-10.
Bacterial Pathogens Activate IFNl
PLOS Pathogens | www.plospathogens.org 9 October 2013 | Volume 9 | Issue 10 | e1003682
15. Carrigan SO, Junkins R, Yang YJ, Macneil A, Richardson C, et al. (2010) IFN
regulatory factor 3 contributes to the host response during Pseudomonas aeruginosa
lung infection in mice. J Immunol 185: 3602–3609. doi:10.4049/jimmu-
nol.0903429.
16. Power MR, Li B, Yamamoto M, Akira S, Lin T-J (2007) A role of Toll-IL-1
receptor domain-containing adaptor-inducing IFN-beta in the host response to
Pseudomonas aeruginosa lung infection in mice. J Immunol 178: 3170–3176.
17. Dennis MD, Jefferson LS, Kimball SR (2012) Role of p70S6K1-mediated
Phosphorylation of eIF4B and PDCD4 Proteins in the Regulation of Protein
Synthesis. Journal of Biological Chemistry 287: 42890–42899. doi:10.1074/
jbc.M112.404822.
18. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, et al. (2003)
IFN-lambdas mediate antiviral protection through a distinct class II cytokine
receptor complex. Nat Immunol 4: 69–77. doi:10.1038/ni875.
19. Liwak U, Thakor N, Jordan LE, Roy R, Lewis SM, et al. (2012) Tumor
Suppressor PDCD4 Represses Internal Ribosome Entry Site-Mediated Trans-
lation of Antiapoptotic Proteins and Is Regulated by S6 Kinase 2. Mol Cell Biol
32: 1818–1829. doi:10.1128/MCB.06317-11.
20. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, et al. (2003)
IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4: 63–68.
doi:10.1038/ni873.
21. de Weerd NA, Nguyen T (2012) The interferons and their receptors--
distribution and regulation. Immunology and Cell Biology 90: 483–491.
doi:10.1038/icb.2012.9.
22. Kroczynska B, Sharma B, Eklund EA, Fish EN, Platanias LC (2012) Regulatory
effects of programmed cell death 4 (PDCD4) protein in interferon (IFN)-
stimulated gene expression and generation of type I IFN responses. Mol Cell Biol
32: 2809–2822. doi:10.1128/MCB.00310-12.
23. Meager A, Visvalingam K, Dilger P, Bryan D, Wadhwa M (2005) Biological
activity of interleukins-28 and -29: comparison with type I interferons. Cytokine
31: 109–118. doi:10.1016/j.cyto.2005.04.003.
24. Maher SG, Sheikh F, Scarzello AJ, Romero-Weaver AL, Baker DP, et al. (2008)
IFNalpha and IFNlambda differ in their antiproliferative effects and duration of
JAK/STAT signaling activity. Cancer Biol Ther 7: 1109–1115.
25. Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, et al. (2008) An
important role for type III interferon (IFN-l/IL-28) in TLR-induced antiviral
activity. J Immunol 180: 2474–2485.
26. Zhou Z, Hamming OJ, Ank N, Paludan SR, Nielsen AL, et al. (2007) Type III
interferon (IFN) induces a type I IFN-like response in a restricted subset of cells
through signaling pathways involving both the Jak-STAT pathway and the
mitogen-activated protein kinases. J Virol 81: 7749–7758. doi:10.1128/
JVI.02438-06.
27. Pulverer JE, Rand U, Lienenklaus S, Kugel D, Zietara N, et al. (2010) Temporal
and spatial resolution of type I and III interferon responses in vivo. J Virol 84:
8626–8638. doi:10.1128/JVI.00303-10.
28. Sommereyns C, Paul S, Staeheli P, Michiels T (2008) IFN-lambda (IFN-l) is
expressed in a tissue-dependent fashion and primarily acts on epithelial cells in
vivo. PLoS Pathog 4: e1000017. doi:10.1371/journal.ppat.1000017.
29. Merline R, Moreth K, Beckmann J, Nastase MV, Zeng-Brouwers J, et al. (2011)
Signaling by the matrix proteoglycan decorin controls inflammation and cancer
through PDCD4 and microRNA-21. Science Signaling 4: ra75–ra75. Available:
http://stke.sciencemag.org/cgi/content/abstract/sigtrans;4/199/ra75.
30. Wang J, Oberley-Deegan R, Wang S, Nikrad M, Funk CJ, et al. (2009)
Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda
1) in response to influenza A infection. J Immunol 182: 1296–1304.
31. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O’Leary JJ, et al.
(2009) Negative regulation of TLR4 via targeting of the proinflammatory tumor
suppressor PDCD4 by the microRNA miR-21. Nat Immunol 11: 141–147.
doi:10.1038/ni.1828.
32. Jewell NA, Cline T, Mertz SE, Smirnov SV, Flano E, et al. (2010) Lambda
interferon is the predominant interferon induced by influenza A virus infection
in vivo. J Virol 84: 11515–11522. doi:10.1128/JVI.01703-09.
33. Yang HS, Jansen AP, Nair R, Shibahara K, Verma AK, et al. (2001) A novel
transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-
kappaB or ODC transactivation. Oncogene 20: 669–676. doi:10.1038/
sj.onc.1204137.
34. Koltsida O, Hausding M, Stavropoulos A, Koch S, Tzelepis G, et al. (2011) IL-
28A (IFN-l2) modulates lung DC function to promote Th1 immune skewing
and suppress allergic airway disease. EMBOMol Med 3: 348–361. doi:10.1002/
emmm.201100142.
35. Gallagher G, Megjugorac NJ, Yu RY, Eskdale J, Gallagher GE, et al. (2010) The
lambda interferons: guardians of the immune-epithelial interface and the T-
helper 2 response. Journal of Interferon & Cytokine Research 30: 603–615.
doi:10.1089/jir.2010.0081.
36. Pekarek V, Srinivas S, Eskdale J, Gallagher G (2007) Interferon lambda-1 (IFN-
l1/IL-29) induces ELR(-) CXC chemokine mRNA in human peripheral blood
mononuclear cells, in an IFN-gamma-independent manner. Genes Immun 8:
177–180. doi:10.1038/sj.gene.6364372.
37. Chastre J, Fagon J-Y (2002) Ventilator-associated pneumonia. Am J Respir Crit
Care Med 165: 867–903.
38. Centers for Disease Control and Prevention (CDC) (2003) Methicillin-resistant
Staphylococcus aureus infections in correctional facilities---Georgia, California, and
Texas, 2001-2003. MMWR Morb Mortal Wkly Rep 52: 992–996.
39. Marcello T, Grakoui A, Barba-Spaeth G, Machlin ES, Kotenko SV, et al. (2006)
Interferons alpha and lambda inhibit hepatitis C virus replication with distinct
signal transduction and gene regulation kinetics. Gastroenterology 131: 1887–
1898. doi:10.1053/j.gastro.2006.09.052.
40. Doyle SE, Schreckhise H, Khuu-Duong K, Henderson K, Rosler R, et al. (2006)
Interleukin-29 uses a type 1 interferon-like program to promote antiviral
responses in human hepatocytes. Hepatology 44: 896–906. doi:10.1002/
hep.21312.
41. Go´mez MI, Seaghdha MO, Prince AS (2007) Staphylococcus aureus protein A
activates TACE through EGFR-dependent signaling. EMBO J 26: 701–709.
doi:10.1038/sj.emboj.7601554.
42. Go´mez MI, Lee A, Reddy B, Muir A, Soong G, et al. (2004) Staphylococcus aureus
protein A induces airway epithelial inflammatory responses by activating
TNFR1. Nat Med 10: 842–848. doi:10.1038/nm1079.
43. Go´mez MI, O’Seaghdha M, Magargee M, Foster TJ, Prince AS (2006)
Staphylococcus aureus protein A activates TNFR1 signaling through conserved IgG
binding domains. J Biol Chem 281: 20190–20196.
44. Palamarchuk A, Efanov A, Maximov V, Aqeilan RI, Croce CM, et al. (2005)
Akt phosphorylates and regulates Pdcd4 tumor suppressor protein. Cancer Res
65: 11282–11286. doi:10.1158/0008-5472.CAN-05-3469.
45. Wedeken L, Singh P, Klempnauer K-H (2011) Tumor suppressor protein Pdcd4
inhibits translation of p53 mRNA. Journal of Biological Chemistry 286: 42855–
42862. doi:10.1074/jbc.M111.269456.
46. Wedeken L, Ohnheiser J, Hirschi B, Wethkamp N, Klempnauer K-H (2010)
Association of tumor suppressor protein Pdcd4 with ribosomes is mediated by
protein-protein and protein-RNA interactions. Genes & Cancer 1: 293–301.
doi:10.1177/1947601910364227.
47. Sato A, Ohtsuki M, Hata M, Kobayashi E, Murakami T (2006) Antitumor
activity of IFN-lambda in murine tumor models. J Immunol 176: 7686–7694.
48. Lasfar A, Lewis-Antes A, Smirnov SV, Anantha S, Abushahba W, et al. (2006)
Characterization of the mouse IFN-lambda ligand-receptor system: IFN-
lambdas exhibit antitumor activity against B16 melanoma. Cancer Res 66:
4468–4477. doi:10.1158/0008-5472.CAN-05-3653.
49. Dickensheets H, Sheikh F, Park O, Gao B, Donnelly RP (2013) Interferon-
lambda (IFN-l) induces signal transduction and gene expression in human
hepatocytes, but not in lymphocytes or monocytes. J Leukoc Biol 93: 377–385.
doi:10.1189/jlb.0812395.
50. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, et al. (2009) Genetic
variation in IL28B predicts hepatitis C treatment-induced viral clearance.
Nature 461: 399–401. doi:10.1038/nature08309.
51. Lebreton A, Lakisic G, Job V, Fritsch L, Tham TN, et al. (2011) A bacterial
protein targets the BAHD1 chromatin complex to stimulate type III interferon
response. Science 331: 1319–1321. doi:10.1126/science.1200120.
52. Suzuki C, Garces RG, Edmonds KA, Hiller S, Hyberts SG, et al. (2008) PDCD4
inhibits translation initiation by binding to eIF4A using both its MA3 domains.
PNAS 105: 3274–3279. doi:10.1073/pnas.0712235105.
53. Liu X, Zhan Z, Xu L, Ma F, Li D, et al. (2010) MicroRNA-148/152 impair
innate response and antigen presentation of TLR-triggered dendritic cells by
targeting CaMKIIa. J Immunol 185: 7244–7251. doi:10.4049/jimmu-
nol.1001573.
54. Liu PT, Wheelwright M, Teles R, Komisopoulou E, Edfeldt K, et al. (2012)
MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in
leprosy. Nat Med 18: 267–273. doi:10.1038/nm.2584.
55. Case SR, Martin RJ, Jiang D, Minor MN, Chu HW (2011) MicroRNA-21
inhibits toll-like receptor 2 agonist-induced lung inflammation in mice. Exp
Lung Res 37: 500–508. doi:10.3109/01902148.2011.596895.
56. Lu TX, Hartner J, Lim E-J, Fabry V, Mingler MK, et al. (2011) MicroRNA-21
limits in vivo immune response-mediated activation of the IL-12/IFN-gamma
pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J
Immunol 187: 3362–3373. doi:10.4049/jimmunol.1101235.
57. Ruan Q, Wang T, Kameswaran V, Wei Q, Johnson DS, et al. (2011) The
microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic
{beta} cell death. PNAS 108: 12030–12035. doi:10.1073/pnas.1101450108/-/
DCSupplemental/pnas.201101450SI.pdf.
58. Parker D, Prince A (2013) Epithelial uptake of flagella initiates proinflammatory
signaling. PLoS ONE 8: e59932. doi:10.1371/journal.pone.0059932.g005.
59. Mijares LA, Wangdi T, Sokol C, Homer R, Medzhitov R, et al. (2011) Airway
epithelial MyD88 restores control of Pseudomonas aeruginosa murine infection via
an IL-1-dependent pathway. J Immunol 186: 7080–7088. doi:10.4049/
jimmunol.1003687.
60. Chun J, Prince A (2009) TLR2-induced calpain cleavage of epithelial junctional
proteins facilitates leukocyte transmigration. Cell Host Microbe 5: 47–58.
doi:10.1016/j.chom.2008.11.009.
Bacterial Pathogens Activate IFNl
PLOS Pathogens | www.plospathogens.org 10 October 2013 | Volume 9 | Issue 10 | e1003682
